Update on Pharmaceutical Market Opportunity

05 October 2017 Dear Investor: As an investor in Applied DNA Sciences you are likely aware of the potential applicability of our DNA molecular taggant platform to counter the growing threat from counterfeits in the global pharmaceutical industry. The World Health Organization estimates that 1% of the drug supply in developed countries is counterfeit — [...]

APDN to Present at 2017 Disruptive Growth Company Showcase

STONY BROOK, N.Y. September 21, 2017 – Applied DNA Sciences, Inc. (NASDAQ: APDN), announced that Dr. James Hayward, president & CEO, will present at the 2017 Disruptive Growth Company Showcase at the Grand Hyatt in New York City on Wednesday, September 27 at 2:30 p.m. ET. Dr. Hayward will present to an audience of investors [...]

APDN Files Form S-3 Registration Statement

STONY BROOK N.Y. (September 18, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced that it has filed a Registration Statement with the Securities and Exchange Commission (the “Registration Statement”) with respect to the sale by certain selling security holders of common stock to be received upon exercise of warrants [...]

Applied DNA Reports Fiscal Third Quarter 2017 Financial Results

STONY BROOK, N.Y., August 10, 2017 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”, or "the Company"), announced financial results for the fiscal 2017 third quarter ended June 30, 2017. "We continued to make excellent progress in driving market adoption of our DNA technology platform in the fiscal third quarter while [...]

Applied DNA Schedules Fiscal 2017 Third Quarter Financial Results Conference Call and Webcast For August 10, 2017 at 4:30 PM ET

STONY BROOK, N.Y. (July 27, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), will host an investor call and simultaneous webcast on Thursday, August 10, 2017 at 4:30 PM ET to discuss its fiscal 2017 third quarter financial results. Dr. James Hayward, president and CEO, and Beth Jantzen, CFO, plan to [...]

Applied DNA Sciences Raises $1.8 Million in Private Placement Led by Executive Officers, Board Members and Strategic Investor

STONY BROOK, N.Y. June 28, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), announces today that it has entered into subscription agreements for a private placement of its Common Stock, par value $.001 per share, with a group of investors, including a key customer and all of the Company’s Executive Officers [...]

Applied DNA and Lily of the Desert to Prove Aloe vera Origin and Authenticity in Finished Goods

Pilot study proves “Molecular SigNatures™” persist from the raw plant to the finished extracts and then to finished nutritional and personal care products. Inherent Aloe DNA does not suffice. 27 June, 2017 Release Details STONY BROOK, N.Y. (June 27, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the company,” NASDAQ: APDN), has completed initial work [...]

Applied DNA Wins Two-Year, $1.5 Million Competitive Development Contract from the Office of the Secretary of Defense

STONY BROOK, N.Y. June 6, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” “the company,” NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics, announced that it has been awarded a two-year, approximately $1.5 million competitive-bid development contract. The award, [...]

Applied DNA Sciences Fighting International Gang Collaboration for Car Theft in Europe

STONY BROOK, NY. May 15, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics, is helping break up international gangs of car thieves. BMW implemented a mandatory DNA marking program in Sweden for new vehicles [...]

Cosmetic Industry Veteran Elizabeth Schmalz Ferguson Joins Board of Directors

STONY BROOK, NY – May 15, 2017 — Applied DNA Sciences, Inc. (Applied DNA, “the Company”) (NASDAQ: APDN), a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics, appointed Elizabeth M. Schmalz Ferguson to the Company’s Board of Directors, effective June 1, 2017. Ms. Ferguson was selected to [...]